IFN-γ Licensing Does Not Enhance the Reduced Immunomodulatory Potential and Migratory Ability of Differentiation-Induced Porcine Bone Marrow-Derived Mesenchymal Stem Cells in an In Vitro Xenogeneic Application

IFN-γ licensing to mesenchymal stem cells (MSCs) is applied to enhance the therapeutic potential of MSCs. However, although the features of MSCs are affected by several stimuli, little information is available on changes to the therapeutic potential of IFN-γ-licensed differentiated MSCs during xenog...

Full description

Bibliographic Details
Main Authors: Hyeon-Jeong Lee, Hwan-Deuk Kim, Chan-Hee Jo, Eun-Yeong Bok, Saet-Byul Kim, Sung-Lim Lee, Min Jang, Seul-Gi Bae, Sung-Ho Yun, Seung-Joon Kim, Gyu-Jin Rho, Won-Jae Lee
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2021/4604856